Speaker illustration

Doctor Masaki Nakagaito

University of Toyama, Toyama (Japan)

Short-term effects of dapagliflozin versus canagliflozin on acute decompensated heart failure in patients with type 2 diabetes

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session: Acute heart failure : new treatment updates


Short term effect of SGLT2 inhibitor, Dapagliflozin added on to standard therapy in decompensated heart failure patients with diabetes mellitus

Event: ESC CONGRESS 2017

Topic: AHF - Drug treatment

Session: Fresh look at heart failure


This platform is supported by

logo Novo Nordisk